Work

PIII-62Metabolism of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, by human cytochrome P-450 CYP3A4, 3A5, 1A1, and 1A2

Year: 2006

Type: article

Source: Clinical Pharmacology & Therapeutics

DOI: 10.1016/j.clpt.2005.12.270

Authors: J LI, M ZHAO, S BAKER

Institution: Johns Hopkins University

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2330701323

FWCI: 0.302

Cites:

Cited by: 2

Related to: 10